Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape [0.03%]
新发2型糖尿病患者的药理学治疗趋势：在不断变化的指南背景下的用药模式
William Hou,Katherine R Tuttle,Weining Shen et al.
William Hou et al.
Aims: In patients with new onset type 2 diabetes, this study aimed to analyze glucose-lowering medication use patterns between 2014 and 2022. Materials an...
Taurine Alleviates Pancreatic β-Cell Senescence by Inhibition of p53 Pathway [0.03%]
牛磺酸通过抑制p53途径缓解胰岛β细胞衰老
Baomin Wang,Ziyan Wang,Yumei Yang et al.
Baomin Wang et al.
Background: Pancreatic β-cells function deteriorates during aging, leading to increased risk of type 2 diabetes. We and others previously demonstrated that p53 activation triggers β-cell senescence and dysfunction in ag...
Time Trends in Cardiovascular Event Incidence in New-Onset Type 2 Diabetes: A Population-Based Cohort Study From Germany [0.03%]
基于德国人群的队列研究：新发2型糖尿病心血管事件发病趋势
Theresia Sarabhai,Karel Kostev
Theresia Sarabhai
Background: Events of cardiovascular disease (CVD) remain a critical concern in patients with Type 2 diabetes mellitus (T2D). Over 17 years, this study analyzed time changes in the 5-year incidence of myocardial infarctio...
Global, Regional, and National Prevalence of Chronic Type 2 Diabetic Kidney Disease From 1990 to 2021: A Trend and Health Inequality Analyses Based on the Global Burden of Disease Study 2021 [0.03%]
1990至2021年全球、区域和国家慢性2型糖尿病肾病患病率及卫生不平等分析（基于全球疾病负担研究2021）
Yujun He,Xiaoyi Wang,Lu Li et al.
Yujun He et al.
Background: Diabetic kidney disease (DKD) is a prevalent and severe complication of diabetes that significantly impacts global health and quality of life. Most DKD is attributable to type 2 diabetes; therefore, chronic ty...
Real-World Persistence and Characteristics of Type 2 Diabetes Patients Prescribed Semaglutide in Scotland [0.03%]
司美格鲁肽在苏格兰2型糖尿病患者中的现实世界持久性和特征属性分析
David Alexander Dickie,Ramil Burden,Alexander C Miller et al.
David Alexander Dickie et al.
Potential Detrimental Interactions Between Metformin and Supplemental Dietary Fiber in Type 2 Diabetes [0.03%]
二甲双胍与膳食纤维补充剂之间的潜在不利相互作用可能会危害2型糖尿病患者的肠道健康
Rosemary M Hall,Amber Parry-Strong,David O&#x;Sullivan et al.
Rosemary M Hall et al.
Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study [0.03%]
睡眠表型、遗传易感性与2型糖尿病患者肥胖风险的相关性：一项全国前瞻性队列研究
Lei Xi,Li Li,Songbo Fu et al.
Lei Xi et al.
Background: To determine the associations between sleep phenotypes and the risks of specific obesity types and weight gain in patients with type 2 diabetes (T2D), especially in different genetic risk groups. ...
Zachary Bloomgarden
Zachary Bloomgarden
Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study [0.03%]
糖化血红蛋白与胆固醇比值与2型糖尿病患者慢性肾脏病进展的相关性：回顾性队列研究
Yanyan Chen,Shanshan Wang,Hang Guo et al.
Yanyan Chen et al.
Aim: To explore the influence of the serum total bilirubin to total cholesterol (TBIL/TC) ratio on the progression of chronic kidney disease (CKD) in people with type 2 diabetes. ...
Telemedicine's Impact on Diabetes Care During the COVID-19 Pandemic: A Cohort Study in a Large Integrated Healthcare System [0.03%]
新冠肺炎疫情期间远程医疗对糖尿病护理的影响：一个大型综合卫生系统的队列研究
Reysha Patel,Jie Huang,Loretta Hsueh et al.
Reysha Patel et al.
Aims: To examine whether patients exposed to primary care telemedicine (telephone or video) early in the COVID-19 pandemic had higher rates of downstream HbA1c measurement and improved HbA1c levels in the second year of t...